These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 39264298)

  • 1. Oral bomb effect nanotherapeutics alleviate ulcerative colitis through coordinated anti-inflammatory and pro-resolving strategies.
    Yang M; Zhu Y; Wei X; Feng J; He Y; Jiang J; Zhou Q; Zhang M; Zhang G; Ma W
    Biomater Sci; 2024 Oct; 12(20):5386-5403. PubMed ID: 39264298
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation.
    Xiao B; Zhang Z; Viennois E; Kang Y; Zhang M; Han MK; Chen J; Merlin D
    Theranostics; 2016; 6(12):2250-2266. PubMed ID: 27924161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An oral pH-activated "nano-bomb" carrier combined with berberine by regulating gene silencing and gut microbiota for site-specific treatment of ulcerative colitis.
    Yang M; Yang C; Zhang Y; Yan X; Ma Y; Zhang Y; Cao Y; Xu Q; Tu K; Zhang M
    Biomater Sci; 2022 Feb; 10(4):1053-1067. PubMed ID: 35037010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Nanotherapeutics of Andrographolide/Carbon Monoxide Donor for Synergistically Anti-inflammatory and Pro-resolving Treatment of Ulcerative Colitis.
    Zhou Y; Yang M; Yan X; Zhang L; Lu N; Ma Y; Zhang Y; Cui M; Zhang M; Zhang M
    ACS Appl Mater Interfaces; 2023 Aug; 15(30):36061-36075. PubMed ID: 37463480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticles with surface antibody against CD98 and carrying CD98 small interfering RNA reduce colitis in mice.
    Xiao B; Laroui H; Viennois E; Ayyadurai S; Charania MA; Zhang Y; Zhang Z; Baker MT; Zhang B; Gewirtz AT; Merlin D
    Gastroenterology; 2014 May; 146(5):1289-300.e1-19. PubMed ID: 24503126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.
    Xiao B; Xu Z; Viennois E; Zhang Y; Zhang Z; Zhang M; Han MK; Kang Y; Merlin D
    Mol Ther; 2017 Jul; 25(7):1628-1640. PubMed ID: 28143741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urocanic acid-modified chitosan nanoparticles can confer anti-inflammatory effect by delivering CD98 siRNA to macrophages.
    Xiao B; Ma P; Viennois E; Merlin D
    Colloids Surf B Biointerfaces; 2016 Jul; 143():186-193. PubMed ID: 27011348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Delivery of Pterostilbene by L-Arginine-Mediated "Nano-Bomb" Carrier for the Treatment of Ulcerative Colitis.
    Wei W; Zhang Y; Li R; Cao Y; Yan X; Ma Y; Zhang Y; Yang M; Zhang M
    Int J Nanomedicine; 2022; 17():603-616. PubMed ID: 35177902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of hyaluronic acid-functionalized magnolol nanoparticles for ulcerative colitis treatment.
    Li Y; Chen T; Chen L; Wu D; Hu J
    Int J Biol Macromol; 2024 May; 268(Pt 2):131920. PubMed ID: 38679261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNFα gene silencing mediated by orally targeted nanoparticles combined with interleukin-22 for synergistic combination therapy of ulcerative colitis.
    Xiao B; Chen Q; Zhang Z; Wang L; Kang Y; Denning T; Merlin D
    J Control Release; 2018 Oct; 287():235-246. PubMed ID: 30107214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Delivery of Nanoparticles Loaded With Ginger Active Compound, 6-Shogaol, Attenuates Ulcerative Colitis and Promotes Wound Healing in a Murine Model of Ulcerative Colitis.
    Zhang M; Xu C; Liu D; Han MK; Wang L; Merlin D
    J Crohns Colitis; 2018 Jan; 12(2):217-229. PubMed ID: 28961808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone-Loaded Lipid Calcium Phosphate Nanoparticles Treat Experimental Colitis by Regulating Macrophage Polarization in Inflammatory Sites.
    Dong K; Zhang Y; Ji HR; Guan ZL; Wang DY; Guo ZY; Deng SJ; He BY; Xing JF; You CY
    Int J Nanomedicine; 2024; 19():993-1016. PubMed ID: 38299194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of particle size on the cellular uptake and anti-inflammatory activity of oral nanotherapeutics.
    Zhou X; Liu Y; Wang X; Li X; Xiao B
    Colloids Surf B Biointerfaces; 2020 Mar; 187():110880. PubMed ID: 32098717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of Intestinal Glycoprotein CD98 by Orally Targeted Nanoparticles Enhances Chemosensitization of Colon Cancer.
    Xiao B; Viennois E; Chen Q; Wang L; Han MK; Zhang Y; Zhang Z; Kang Y; Wan Y; Merlin D
    ACS Nano; 2018 Jun; 12(6):5253-5265. PubMed ID: 29860836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of Amauroderma rugosum on dextran sulfate sodium-induced ulcerative colitis through the regulation of macrophage polarization and suppression of oxidative stress.
    Li J; Luo X; Shiu PH; Cheng Y; Nie X; Rangsinth P; Lau BWM; Zheng C; Li X; Li R; Lee SM; Fu C; Seto SW; Zhang J; Leung GP
    Biomed Pharmacother; 2024 Jul; 176():116901. PubMed ID: 38878683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of particle size and binding affinity for small interfering RNA on the cellular processing, intestinal permeation and anti-inflammatory efficacy of polymeric nanoparticles.
    Cheng W; Tang C; Yin C
    J Gene Med; 2015; 17(10-12):244-56. PubMed ID: 26418829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orally targeted galactosylated chitosan poly(lactic-co-glycolic acid) nanoparticles loaded with TNF-ɑ siRNA provide a novel strategy for the experimental treatment of ulcerative colitis.
    Huang Y; Guo J; Gui S
    Eur J Pharm Sci; 2018 Dec; 125():232-243. PubMed ID: 30315858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional Ginger-Derived Extracellular Vesicles-Coated ZIF-8 Containing TNF-α siRNA for Ulcerative Colitis Therapy by Modulating Gut Microbiota.
    Cui C; Du M; Zhao Y; Tang J; Liu M; Min G; Chen R; Zhang Q; Sun Z; Weng H
    ACS Appl Mater Interfaces; 2024 Oct; 16(40):53460-53473. PubMed ID: 39303016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronic acid-functionalized DDAB/PLGA nanoparticles for improved oral delivery of magnolol in the treatment of ulcerative colitis.
    Li W; Lin J; Zhou J; He S; Wang A; Hu Y; Li H; Zou L; Liu Y
    Int J Pharm; 2024 Mar; 653():123878. PubMed ID: 38325622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demethylzeylasteral alleviates inflammation and colitis via dual suppression of NF-κB and STAT3/5 by targeting IKKα/β and JAK2.
    Wen T; Liu T; Chen H; Liu Q; Shen X; Hu Q
    Int Immunopharmacol; 2024 Dec; 142(Pt B):113260. PubMed ID: 39340986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.